| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/07/2023 | 400% | Cantor Fitzgerald | → $4 | Reiterates | Overweight → Overweight |
| 08/07/2023 | 400% | Cantor Fitzgerald | $6 → $4 | Maintains | Overweight |
| 12/19/2022 | 87.5% | B. Riley Securities | $6 → $1.5 | Maintains | Neutral |
| 09/02/2022 | 900% | Cantor Fitzgerald | $11 → $8 | Maintains | Overweight |
| 05/19/2022 | 650% | B. Riley Securities | $7 → $6 | Maintains | Neutral |
| 11/02/2021 | 1775% | Cantor Fitzgerald | → $15 | Initiates Coverage On | → Overweight |
| 06/30/2021 | 1025% | B. Riley Securities | $13 → $9 | Downgrades | Buy → Neutral |
| 06/24/2021 | 1525% | Jefferies | → $13 | Initiates Coverage On | → Buy |
| 06/11/2021 | 2150% | Piper Sandler | → $18 | Initiates Coverage On | → Overweight |
| 08/12/2020 | 2025% | HC Wainwright & Co. | $7 → $17 | Maintains | Buy |
| 07/13/2020 | 2650% | B. Riley Securities | → $22 | Initiates Coverage On | → Buy |
| 04/30/2020 | 775% | HC Wainwright & Co. | $3 → $7 | Reiterates | → Buy |
| 06/27/2019 | 150% | HC Wainwright & Co. | → $2 | Initiates Coverage On | → Buy |
What is the target price for Vaxart (VXRT)?
The latest price target for Vaxart (NASDAQ: VXRT) was reported by Cantor Fitzgerald on September 7, 2023. The analyst firm set a price target for $4.00 expecting VXRT to rise to within 12 months (a possible 400.00% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Vaxart (VXRT)?
The latest analyst rating for Vaxart (NASDAQ: VXRT) was provided by Cantor Fitzgerald, and Vaxart reiterated their overweight rating.
When is the next analyst rating going to be posted or updated for Vaxart (VXRT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vaxart, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vaxart was filed on September 7, 2023 so you should expect the next rating to be made available sometime around September 7, 2024.
Is the Analyst Rating Vaxart (VXRT) correct?
While ratings are subjective and will change, the latest Vaxart (VXRT) rating was a reiterated with a price target of $0.00 to $4.00. The current price Vaxart (VXRT) is trading at is $0.80, which is within the analyst's predicted range.